VeriMomIst disodium c12-14 sec-pareth-7 sulfosuccinate in der Schwangerschaft sicher?
No harmonised CLP reproductive classifications found (ECHA Annex VI). No CIR or SCCS safety assessment flagging reproductive toxicity, and PubMed contains no credible reproductive/toxicology studies indicating teratogenicity or reproductive hazards for this specific sulfosuccinate; ECHA/PubChem entries list typical surfactant toxicology (irritation at high concentrations) but not reproductive endpoints. Topical cosmetic use would give low but measurable dermal exposure (surfactants have limited systemic absorption). Sources: ECHA Annex VI (no harmonised repro classification), PubChem, CosIng, PubMed (no reproductive studies found).
Related ingredients
Frequently asked questions
- Ist disodium c12-14 sec-pareth-7 sulfosuccinate in der Schwangerschaft sicher?
- No harmonised CLP reproductive classifications found (ECHA Annex VI). No CIR or SCCS safety assessment flagging reproductive toxicity, and PubMed contains no credible reproductive/toxicology studies indicating teratogenicity or reproductive hazards for this specific sulfosuccinate; ECHA/PubChem entries list typical surfactant toxicology (irritation at high concentrations) but not reproductive endpoints. Topical cosmetic use would give low but measurable dermal exposure (surfactants have limited systemic absorption). Sources: ECHA Annex VI (no harmonised repro classification), PubChem, CosIng, PubMed (no reproductive studies found).
- Ist disodium c12-14 sec-pareth-7 sulfosuccinate während des Stillens sicher?
- No data indicating reproductive or lactation toxicity or transfer into milk in ECHA/CIR/SCCS/PubMed sources. Mechanistic data for placental/milk transfer are absent. Dermal exposure in lactating persons is expected to be low but measurable; no evidence of systemic accumulation or endocrine activity that would raise concern. Sources: ECHA (registration/Cosing entries), PubChem, PubMed (no lactation studies).
- Ist disodium c12-14 sec-pareth-7 sulfosuccinate sicher für Babyhaut?
- No infant-specific reproductive or developmental toxicity data were identified. Because infants (0–3 yr) have an immature skin barrier and higher surface-area-to-weight ratio, exposure score is increased by +1 versus adults (adult e=1 → infant e=2). No evidence found for specific mechanisms (endocrine activity) or harmonised reproductive hazards. Sources: CosIng, ECHA registrations, PubChem, PubMed (no infant dermal absorption/reprotox studies).
- Wie bewertet VeriMom disodium c12-14 sec-pareth-7 sulfosuccinate?
- VeriMom bewertet disodium c12-14 sec-pareth-7 sulfosuccinate mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu disodium c12-14 sec-pareth-7 sulfosuccinate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu disodium c12-14 sec-pareth-7 sulfosuccinate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.